Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD)

Nowadays, nonalcoholic fatty liver disease is a common metabolic liver disease of all ages worldwide. However, current pharmacological and surgical treatments are accompanied with side effects and complications. EndoBarrier, a less invasive bariatric surgery, blocks the upper portion of the intestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Yong-Chen, Chen, Tzu-Chien, Tang, Rui-Chian, Lin, Jhih-Ni, Lin, Feng-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828268/
https://www.ncbi.nlm.nih.gov/pubmed/35178496
http://dx.doi.org/10.1063/5.0081695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828268/
https://www.ncbi.nlm.nih.gov/pubmed/35178496
http://dx.doi.org/10.1063/5.0081695

Ejemplares similares